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Introduction
Granulomatosis with polyangiitis (GPA) is a rare disease
in childhood. Treatment strategies and clinical approach
are still mostly derived from adult GPA studies.
Objectives
The present study was aimed to compare disease onset
and course, therapeutic approach and clinical outcome
of two cohorts of children and adults affected by GPA.
Methods
The study included children and adult patients selected
on the basis of complete data set and follow up of at
least one year, followed at the pediatric and adult Rheu-
matology Centers, University Hospital of Padua, over a
period of 20 years (1993-2013). GPA was diagnosed
according to the ACR and EULAR/PRES criteria. Clinical
features, instrumental findings, laboratory parameters and
therapeutic regimens of both cohorts were analyzed at
diagnosis, six months later (T6) and at the last follow-up
visit. Disease activity was assessed by the Birmingham
Vasculitis Activity Score (BVAS) modified for GPA.
Results
Ten children with mean age at disease onset of 10.3 years
(range 3-15) entered the study, 6/9 were female. Mean
follow-up time was 8.4 years (range 2.5-18). Of the 23
adults 65.3% were female, mean age at onset 53 years
(range 37-71) and mean follow-up 1.9 years (range 1-3.5).
At disease onset, BVAS, clinical features and laboratory
parameters of the two cohorts were not significantly
different. BVAS decreased more slowly in children
(p 0.002). As for internal organs involvement, renal dis-
ease was significantly higher at T6 and persisted over
time in children (p 0.003). Similarly, pulmonary disease
remained elevated at T6 while decreased over 50% in
adults (p 0.01). At the last F/U visit, eye involvement was
present in 44% of children while no adult showed signs
of ocular disease (p 0.004). Regarding to the treatment
strategies, immunosuppressive drugs were more widely
used in children at diagnosis (p 0.06) and biological
agents were used at an earlier disease stage than adults.
Despite the longer follow up, all children were still on
treatment at the last visit while 17% of adults were off
therapy.
Conclusion
Adults and children with GPA had similar disease activity
at onset. However, childhood GPA had a more severe-
course due to persistent renal, pulmonary and eye involve-
ment. Lower disease activity was obtained with a more
aggressive treatment approach although no pediatric
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